Free Trial
→ Do this before December or regret it (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avinger, Inc. stock logo
AVGR
Avinger
$0.47
$0.47
$0.36
▼
$1.93
$1.57M1.291.46 million shsN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
$1.48
-2.0%		$2.10
$1.45
▼
$24.90
$5.01M4.3141,416 shs213,695 shs
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
$7.97
-2.2%		$9.92
$7.01
▼
$28.70
$5.66M1.2926,333 shs46,803 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$1.28
$1.08
$0.02
▼
$1.90
$6.11M1.861,247 shsN/A
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avinger, Inc. stock logo
AVGR
Avinger
0.00%0.00%0.00%0.00%0.00%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
-1.99%-6.33%-30.52%-35.37%-86.17%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-2.21%-3.10%-24.02%-25.93%-69.27%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%+28.00%-1.54%+56.10%+220.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avinger, Inc. stock logo
AVGR
Avinger
$0.47
$0.47
$0.36
▼
$1.93
$1.57M1.291.46 million shsN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
$1.48
-2.0%		$2.10
$1.45
▼
$24.90
$5.01M4.3141,416 shs213,695 shs
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
$7.97
-2.2%		$9.92
$7.01
▼
$28.70
$5.66M1.2926,333 shs46,803 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$1.28
$1.08
$0.02
▼
$1.90
$6.11M1.861,247 shsN/A
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avinger, Inc. stock logo
AVGR
Avinger
0.00%0.00%0.00%0.00%0.00%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
-1.99%-6.33%-30.52%-35.37%-86.17%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-2.21%-3.10%-24.02%-25.93%-69.27%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%+28.00%-1.54%+56.10%+220.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avinger, Inc. stock logo
AVGR
Avinger
0.00
N/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
1.50
ReduceN/AN/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
2.33
HoldN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest AVGR, SONX, NVNO, and INBS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/25/2026
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
7/17/2026
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
(Data available from 10/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avinger, Inc. stock logo
AVGR
Avinger
$7.65M0.21N/AN/A($4.53) per share-0.10
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
$4.22M1.16N/AN/A$2.21 per share0.67
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/A$41.38 per shareN/A
Sonendo, Inc. stock logo
SONX
Sonendo
$44.40M0.14N/AN/A$89.42 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avinger, Inc. stock logo
AVGR
Avinger
-$18.32M-$11.06N/AN/AN/AN/AN/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
-$12.43M-$9.02N/AN/AN/A-294.88%-175.35%-91.25%11/11/2026 (Estimated)
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$19.47M-$19.33N/AN/AN/AN/A-62.28%-56.83%10/30/2026 (Estimated)
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$71.12N/AN/AN/A-92.74%-184.01%-68.60%11/11/2026 (Estimated)

Latest AVGR, SONX, NVNO, and INBS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/11/2026N/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
-$1.31N/AN/AN/A$1.40 millionN/A
11/11/2026N/A
Sonendo, Inc. stock logo
SONX
Sonendo
-$118.00N/AN/AN/A$7.79 millionN/A
10/30/2026N/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$3.27N/AN/AN/A$2.25 millionN/A
7/30/2026Q2 2026
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$4.69-$5.37-$0.68-$5.37$1.00 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Avinger, Inc. stock logo
AVGR
Avinger
N/AN/AN/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
N/AN/AN/AN/AN/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avinger, Inc. stock logo
AVGR
Avinger
N/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
N/A
1.44
1.35
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/A
11.70
11.70
Sonendo, Inc. stock logo
SONX
Sonendo
0.55
1.82
1.22

Institutional Ownership

CompanyInstitutional Ownership
Avinger, Inc. stock logo
AVGR
Avinger
18.30%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
32.97%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
34.71%
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%

Insider Ownership

CompanyInsider Ownership
Avinger, Inc. stock logo
AVGR
Avinger
42.80%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
1.27%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
15.00%
Sonendo, Inc. stock logo
SONX
Sonendo
7.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avinger, Inc. stock logo
AVGR
Avinger
703.31 million1.89 millionNot Optionable
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
603.32 million3.28 millionNot Optionable
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
33690,000591,000No Data
Sonendo, Inc. stock logo
SONX
Sonendo
2504.78 million393,000Not Optionable

Recent News About These Companies

Sonendo Achieves Milestone of Two Million Patients Treated with the GentleWave® Procedure
September 21, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260921529965/en/sonendo-achieves-milestone-of-two-million-patients-treated-with-the-gentlewave%c2%ae-procedure/
Sonendo Announces Key Initiatives to Drive Business Towards Cashflow Break-Even
August 25, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260825390808/en/sonendo-announces-key-initiatives-to-drive-business-towards-cashflow-break-even/
Sonendo, Inc. to Report Third Quarter 2024 Financial Results on November 12, 2024
June 26, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20241029781245/en/Sonendo-Inc.-to-Report-Third-Quarter-2024-Financial-Results-on-November-12-2024
Sonendo Stock Price, Quotes and Forecasts | OTC:SONX | Benzinga
April 8, 2026  |  benzinga.comhttps://www.benzinga.com/quote/SONX
Sonendo, Inc. on Path to Breakeven in the Second Half of 2026
March 16, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260316143036/en/sonendo-inc.-on-path-to-breakeven-in-the-second-half-of-2026/
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to ...
August 22, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250820399898/en/Sonendo-Strengthens-Leadership-Team-With-Promotion-of-John-McGaugh-to-Chief-Operating-Officer
Sonendo names John McGaugh COO
August 20, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/sonendo-names-john-mcgaugh-coo/ar-AA1KU4kG
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer
August 20, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250820399898/en/Sonendo-Strengthens-Leadership-Team-With-Promotion-of-John-McGaugh-to-Chief-Operating-Officer/
Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance
August 13, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250813720540/en/sonendo-inc.-reports-second-quarter-2025-financial-results-and-reaffirms-financial-guidance/
Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance
June 4, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250604534828/en/Sonendo-Inc.-Reports-First-Quarter-2025-Financial-Results-and-Issues-Financial-Guidance/
Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
March 26, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250326534061/en/sonendo-inc.-reports-fourth-quarter-and-full-year-2024-financial-results/
Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
November 11, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241111083660/en/sonendo-inc.-to-release-third-quarter-2024-financial-results-and-postpone-conference-call-on-november-12-2024/
Sonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
November 5, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2364453/sonendo-inc-sonx-may-report-negative-earnings-know-the-trend-ahead-of-next-week-s-release?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_9-2364453
Sonendo Launches ProControlTM for the GentleWave® G4 System
October 23, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241023284533/en/sonendo-launches-procontroltm-for-the-gentlewave%c2%ae-g4-system/
Sonendo, Inc. Announces Preliminary Third Quarter 2024 Financial Results
October 10, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241010657314/en/sonendo-inc.-announces-preliminary-third-quarter-2024-financial-results/
BIOLASE files for Chapter 11, plans asset sale to Sonendo
October 3, 2024  |  investing.comhttps://www.investing.com/news/company-news/biolase-files-for-chapter-11-plans-asset-sale-to-sonendo-3643778
Here's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock Now
August 27, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2327671/here-s-why-sonendo-sonx-is-a-great-buy-the-bottom-stock-now?cid=cs-stocknewsapi-ft-tale_of_the_tape|hammer_chart_pattern_(ta)-2327671
Sonendo Inc.
August 17, 2024  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/SONX/financials/secfilings
Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript
August 10, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4713322-sonendo-inc-sonx-q2-2024-earnings-call-transcript
Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates
August 7, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2318510/sonendo-inc-sonx-reports-q2-loss-tops-revenue-estimates?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_4-2318510

New MarketBeat Followers Over Time

Media Sentiment Over Time

Avinger stock logo

Avinger NASDAQ:AVGR

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Intelligent Bio Solutions stock logo

Intelligent Bio Solutions NASDAQ:INBS

$1.48 -0.03 (-1.99%)
Closing price 10/13/2026 03:59 PM Eastern
Extended Trading
$1.52 +0.04 (+2.77%)
As of 10/13/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

enVVeno Medical stock logo

enVVeno Medical NASDAQ:NVNO

$7.97 -0.18 (-2.21%)
Closing price 10/13/2026 04:00 PM Eastern
Extended Trading
$8.66 +0.69 (+8.71%)
As of 10/13/2026 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

Sonendo stock logo

Sonendo NYSE:SONX

$1.28 0.00 (0.00%)
As of 10/12/2026

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas